• Strong start in the first half of 2027 financial year
• Expected revenue of approximately $1.24 billion
• Anticipated net profit after tax of approximately $280 million
• Updated full year outlook with improved guidance
• 2026 Annual Shareholders' Meeting scheduled for 25 August 2026

Fisher & Paykel Healthcare Corporation Limited has provided guidance for the first half of the 2027 financial year, which ends 30 September 2026. The company expects revenue of approximately $1.24 billion and net profit after tax of approximately $280 million. This reflects a 14% growth in operating revenue and 24% growth in net profit after tax compared to the first half of the 2026 financial year. The full year outlook has also been updated, with expected operating revenue in the range of approximately $2.47 billion to $2.57 billion and net profit after tax in the range of approximately $525 million to $565 million. The company anticipates an overall improvement in gross margin and maintains assumptions about current global tariff rates, policies, and applications.

Revenue: ~$1.24 billion, Net Profit After Tax: ~$280 million for H1 2027

Fisher & Paykel Healthcare expects full year operating revenue to be in the range of approximately $2.47 billion to $2.57 billion and net profit after tax to be in the range of approximately $525 million to $565 million for the 2027 financial year.